TAS0728 |
|
رقم الكتالوجGC65310
|
TAS0728 هو مثبط HER2 قوي ، انتقائي ، فعال عن طريق الفم ، لا رجعة فيه ، ملزم تساهمي ، مع IC50 من 13 نانومتريُظهر TAS0728 أيضًا IC50s من 4.9 و 8.5 و 31 و 65 و 33 و 25 و 86 نانومتر لـ BMX 、 HER4 、 BLK 、 EGFR 、 JAK3 、 SLK و LOK على التواليعلاوة على ذلك ، يُظهر TAS0728 تثبيطًا قويًا ومستدامًا للفسفرة لـ HER2 b و HER3 والمؤثرات النهائية
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2088323-16-2
Sample solution is provided at 25 µL, 10mM.
TAS0728 is a potent, selective, orally active, irreversible and covalent-binding HER2 inhibitor, binds to HER2 at C805, inhibits its kinase activity, with an IC50 of 13 nM. TAS0728 shows IC50s of 4.9, 8.5, 31, 65, 33, 25, 86 and 36 nM for BMX, HER4, BLK, EGFR, JAK3, SLK, LOK and human HER2, respectively. TAS0728 also inhibits the phosphorylation of HER2, HER3, and downstream effectors, shows no obvious effect on EGFR. Antitumor activity[1].
[1]. Irie H, et al. TAS0728, a covalent-binding, HER2-selective kinase inhibitor shows potent antitumor activity in preclinical models. Mol Cancer Ther. 2019 Feb 20.
HER4 8.5nM(IC50) | HER2 13nM(IC50) | HumanHER2 36nM(IC50) | EGFR 65nM(IC50) | BMX 4.9nM(IC50) | BLK 31nM(IC50) | JAK3 33nM(IC50) | SLK 25nM(IC50) | LOK 86nM(IC50) |
| Cas No. | 2088323-16-2 | SDF | |
| Formula | C26H32N8O3 | M.Wt | 504.58 |
| الذوبان | DMSO : 125 mg/mL (247.73 mM; Need ultrasonic) | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.9818 mL | 9.9092 mL | 19.8185 mL |
| 5 mM | 396.4 μL | 1.9818 mL | 3.9637 mL |
| 10 mM | 198.2 μL | 990.9 μL | 1.9818 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)















